William (Bill) DeVaul is the General Counsel, Corporate Secretary and Chief Compliance Officer at Morphic Therapeutic. William attended Boston University School of Law.
William DeVaul is a highly experienced professional with 27.9 years of work experience in the intellectual property and pharmaceutical industry. He has a strong background in patent litigation, patent prosecution, and trademarks. Currently, he serves as the General Counsel, Corporate Secretary, and Chief Compliance Officer at Morphic Therapeutic in Cambridge, Massachusetts. Prior to this, he held various positions at Evelo Biosciences and GE Healthcare. With a focus on biotechnology and life sciences, DeVaul has a proven track record in strategy, copyright law, and technology transfer.
Waltham,Massachusetts,United States
Pharmaceutical Manufacturing
Cambridge,Massachusetts,United States
Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer. Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases and EDP1908 for the treatment of cancer. Evelo is advancing additional product candidates in other disease areas.
Lexington,Massachusetts,United States
Effective January 22, 2015, Cubist Pharmaceuticals is now a wholly owned subsidiary of Merck & Co., Inc. For continued news and updates, we encourage you to follow Merck on LinkedIn at https://www.linkedin.com/company/merck to stay in touch and learn more.
Boston,Massachusetts,United States
Foley Hoag is an award-winning, mid-sized, international law firm that focuses on innovative industries and high-stakes litigation. The diverse backgrounds, perspectives and experiences of our lawyers and business services professionals contribute to the exceptional service we deliver to clients. We have offices in Boston, Denver, New York, Paris and Washington, D.C. For more information, visit www.foleyhoag.com.
United States
Intellectual Property Law
Intellectual Property
Pharmaceutical Industry
Patent Litigation
Patents
Biotechnology
Patent Prosecution
Life Sciences
Trademarks
Litigation
Patentability
Trade Secrets
Strategy
Copyright Law
Technology Transfer
Licensing
Due Diligence
Medical Devices
Freedom To Operate
Ip Strategy
Biopharmaceuticals
We found 1 William DeVaul's email addresses
We found 2 William DeVaul's phone numbers
William DeVaul's social media include: Linkedin,
William DeVaul works for Morphic Therapeutic
William DeVaul's role in Morphic Therapeutic is General Counsel | Corporate Secretary
William DeVaul's latest job experience is General Counsel | Corporate Secretary at Morphic Therapeutic
William DeVaul's latest education in Boston University School of Law